Abstract
Previous studies have shown that acyl‐coenzyme A:cholesterol acyl transferase (ACAT), an enzyme that controls cellular equilibrium between free cholesterol and cholesteryl esters, modulates proteolytic processing of APP in cell‐based and animal models of Alzheimer's disease. Here we report that ACAT‐1 RNAi reduced cellular ACAT‐1 protein by ∼50% and cholesteryl ester levels by 22% while causing a slight increase in the free cholesterol content of ER membranes. This correlated with reduced proteolytic processing of APP and 40% decrease in Aβ secretion. These data show that even a modest decrease in ACAT activity can have robust suppressive effects on Aβ generation.

This publication has 12 references indexed in Scilit: